Diagnosis of PCa begins with a digital rectal examination (DRE) and prostate specific antigen (PSA) measurement, complemented by imaging, such as multiparameter magnetic resonance imaging (mpMRI), and is finally confirmed by trans-rectal or trans-perineal prostate biopsy. Here, KLK3 is linked to posterior cortical atrophy.